Understanding Cancer Clusters: What You Need to Know
Consider the concept of a cancer cluster, which is an unusual concentration of cancer cases in a specific region over a specific period of time.
“No cancer signal detected.” Without much fanfare, the blood test results showed up on my online health portal. The doctor talked about it with me later and congratulated me on the “wow” results.
I took the Galleri Multiple Cancer Early Detection (MCED) test about a year ago, in 2024, as part of a longevity-focused stay at Canyon Ranch, a luxury wellness retreat in Tucson, Arizona. Gallery Lee – Which Cost $949Currently not FDA approved – a blood test that studies fragments of DNA shed into the bloodstream. Patients need a prescription before they can pull up their sleeves.
Galleri’s parent company, GRAIL, recently published results In a study of 25,000 healthy adults aged 50 and older, the company said the test detected cancer at an early stage and in organs that did not undergo routine screening. Gallery Lee discovered signs of cancer in 216 people, 133 of whom actually had cancer. It also predicted the origin of cancer 92% accurately.
“We can isolate these DNA fragments, sequence them, and look for tumor-specific markers in the blood,” he says. megan hallHe is Vice President of Healthcare and Corporate Affairs at GRAIL. When a “cancer signal” is detected, it provides a prediction of the origin of the cancer signal or provides clues to providers and patients as to which organ the signal may come from. For example, if its origin is the pancreas, your doctor will know where to start looking for possible cancer.
“Key takeaways: (this type of testing) May “It complements current screening by identifying lethal cancers that go undetected early and have limited downstream burden,” he says. Dr. Mohammed AbajedChair and Professor of Radiation Oncology at Northwestern University. He did not participate in the study.
The biggest question: Is this the future of cancer treatment? A simple blood test? It’s not that easy. The company’s new study is promising, but it may not take you away from recommended colonoscopies and mammograms.
Hidden cancer ‘waiting to be found’
Several companies are trying to detect cancer through blood tests. But GRAIL is something you hear about in the mainstream thanks to funding for large-scale international prospective clinical trials.
“As we progressed with our research, it became clear to me that we were discovering some new cancers at an early stage that had previously been undetectable,” he says. Dr. Nima Nababizadehis a radiation oncologist at Oregon Health and Science University and author of GRAIL’s Pathfinder 2 study presented at the European Society for Medical Oncology Congress in October.
We screen extensively for only five cancers in the United States: breast, colon, prostate, cervix, and lung, the latter only for high-risk patients. However, 70% of cancer deaths occur in people who do not receive recommended screening tests. This is where Galleri hopes to split the difference.
“Other than these blood tests, most of the cancers that are commonly found are either by chance or because someone has symptoms associated with it,” Nabavizadeh says.
This test also does not detect some cancers, such as prostate cancer. However, there is already an effective diagnostic tool known as the PSA test. Why is Gallery Lee better at detecting certain cancers than others? Some shed more DNA than others. That is, for head and neck cancer, pancreatic cancer and prostate cancer.
Interest in this test has grown. More than 15,000 health care providers have prescribed it, and health systems such as Rush University Health System in Chicago, Community Health Network in Indiana and Mercy in Missouri also offer it.
Dr. Elizabeth O’DonnellThe test is “a really good starting point to potentially address a huge unmet need in medicine,” said the director of the Multi-Cancer Early Discovery Clinic at Dana-Farber Cancer Institute.
‘A positive blood test is not a diagnosis’
Be careful, Galleri can pick you up. lazy cancer – i.e. a slow-growing condition, such as chronic lymphocytic leukemia – you and your healthcare provider may decide not to treat or just watch.
“We want to make sure we’re detecting the more aggressive cancers that actually need treatment,” Hall said.
Overall, both doctors participating in the study and those not participating are not worried about galley testing, overdiagnosis, and sending people down a path of endless, unnecessary treatments. About 1% of people receive a positive cancer detection signal. This means that 99% of people go about their lives and get their normal recommended checkups.
But, he says, “a positive blood test is not diagnostic.” Gilberto Lopez, MDHe is director of oncology at Sylvester Comprehensive Cancer Center, part of the University of Miami Health System. “You still need imaging and sometimes biopsies. That takes time and resources.” Healthcare systems and providers must be prepared for patient questions and anxieties, especially regarding positive outcomes.
Gallery Lee’s uncertain FDA approval path
GRAIL is optimistic about FDA approval for Galleri. This could become more accessible if private insurers and Medicare reimburse doctors for the cost of running the test. But according to Abazeed, the FDA will want to see evidence that early detection means a reduced risk of late-stage cancer or death. And it’s not available yet.
If the data supports it, this is a game changer. “But practical implementation requires more, including standardized diagnostic algorithms, confirmatory imaging and biopsies, and appropriate safeguards to ensure consistent follow-up,” Abazeed said.
When it comes to cancer treatment, something needs to change, O’Donnell says. Of course, people with cancer live longer, but if the disease is caught early, it is treatable. “Anyone who has been in practice long enough knows that something has to be done differently,” says O’Donnell.
My negative results didn’t surprise me. I had no symptoms of cancer, and given that age is the biggest risk factor for developing cancer, the test was intended for people over 50 (I was 32 at the time) anyway. But it was still nice to know that deadly cancer wasn’t just lurking in some random organ.
Before getting tested yourself, make sure you read all precautions and talk to a trusted healthcare provider first. The statement “no signs of cancer detected” was comforting to me and the other 99%, but it was not a lifetime guarantee.
